MicroPort NeuroTech Ltd

Price Chart

Risk-Adjusted Performance

MicroPort NeuroTech Ltd (2172) Price Performance

MicroPort NeuroTech Ltd (2172) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at HKD10.60, down 1.30% from the previous close.

Over the past year, 2172 has traded between a low of HKD9.09 and a high of HKD16.03. The stock has lost 13.6% over this period. It is currently 33.9% below its 52-week high.

MicroPort NeuroTech Ltd has a market capitalization of $6.43B, with a price-to-earnings ratio of 27.90 and a dividend yield of 1.33%.

About MicroPort NeuroTech Ltd

MicroPort NeuroScientific Corporation provides neuro-interventional medical devices. The company offers NUMEN, a coil embolization system; NUMEN FR, a coil detachment system; NUMEN Silk, a 3D electronically detachable coil; Numen Lighting, a coil embolization system; Numen Nest, a detachable coil; NuFairy absorbable coil embolization system; Tubridge, a flow-diverting stent; Tubridge Plus, a flow-diverting stent; WILLIS, a intracranial stent graft system; Comaneci, a embolization assist device; and Rebridge, an intracranial visualized stent for intracranial aneurysm, as well as liquid embolic agent for cerebral arteriovenous malformations. It also offers APOLLO intracranial stent system for intracranial atherosclerosis; Bridge rapamycin target eluting and Bridge MAX rapamycin target eluting vertebral artery stent system for vertebral artery stenosis; Diveer intracranial balloon dilatation catheter, intracranial drug-coated balloon catheter system, intracranial self-expanding rapamycin target eluting stent, and intracranial balloon-expandable rapamycin target eluting stent for intracranial stenosis; and Carotid stent system, Safecer embolic protection device, and PathFinder carotid balloon dilation catheter for carotid artery stenosis. In addition, the company provides NeuroHawk thrombectomy device, NeuroHawk pass17/21 and medibox thrombectomy device and accessories, Tigertriever revascularization device, WAVE-track intracranial aspiration catheter, X-track intracranial distal access catheter, and NeuroGuard neurovascular balloon guide catheter for acute ischemic stroke. Further, it offers U-track intracranial support catheter system, Fastrack microcatheter system, QUEEN-track and 17 Microcatheter, Veyronwire neurovascular guide wire, Sheathru delivery catheter, and filter extension tube for single use. The company was founded in 2004 and is headquartered in Shanghai, China. MicroPort NeuroScientific Corporation is a subsidiary of MicroPort Scientific Corporation.